Cargando…

Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017

OBJECTIVES: Being a Caribbean country, the Dominican Republic is considered endemic for HTLV-1. Viral screening in blood banks is recommended for this blood borne infection. The purpose of this work is to analyze the seroprevalence and trends of HTLV-1/2 in the Dominican Republic blood donors; it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Eusebio-Ponce, Emiliana, Candel, Francisco Javier, Paulino-Ramirez, Robert, Serrano-García, Irene, Anguita, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876899/
https://www.ncbi.nlm.nih.gov/pubmed/33305921
http://dx.doi.org/10.37201/req/117.2020
_version_ 1783650055793672192
author Eusebio-Ponce, Emiliana
Candel, Francisco Javier
Paulino-Ramirez, Robert
Serrano-García, Irene
Anguita, Eduardo
author_facet Eusebio-Ponce, Emiliana
Candel, Francisco Javier
Paulino-Ramirez, Robert
Serrano-García, Irene
Anguita, Eduardo
author_sort Eusebio-Ponce, Emiliana
collection PubMed
description OBJECTIVES: Being a Caribbean country, the Dominican Republic is considered endemic for HTLV-1. Viral screening in blood banks is recommended for this blood borne infection. The purpose of this work is to analyze the seroprevalence and trends of HTLV-1/2 in the Dominican Republic blood donors; it is focused on Santo Domingo, the capital of the country, which has the largest blood donation activity. We also aim at comparing our findings with published data from neighboring countries. PATIENTS AND METHODS: We performed a retrospective cross-sectional study of 10 blood centers of Santo Domingo, which reported HTLV and the other blood-transmitted infections in full. They represent more than 40% of the province’s blood donations. Annual seroprevalence of HTLV-1/2, period prevalence (2012-2017), and time trend were determined. RESULTS: A total of 352,960 blood donations were evaluated. The HTLV-1/2 period prevalence was 0.26% (929/352,960) (95% CI: 0.24–0.28%). We also found a marked predominance of replacement donation (90.4%) in comparison to voluntary contributions (9.6%). Therefore, this blood donor study may provide clues on the general prevalence of the infection. CONCLUSIONS: Seroprevalence of HTLV-1/2 in blood donors of Santo Domingo, Dominican Republic, showed a relatively low and steady trend in the studied period.
format Online
Article
Text
id pubmed-7876899
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-78768992021-02-22 Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017 Eusebio-Ponce, Emiliana Candel, Francisco Javier Paulino-Ramirez, Robert Serrano-García, Irene Anguita, Eduardo Rev Esp Quimioter Original OBJECTIVES: Being a Caribbean country, the Dominican Republic is considered endemic for HTLV-1. Viral screening in blood banks is recommended for this blood borne infection. The purpose of this work is to analyze the seroprevalence and trends of HTLV-1/2 in the Dominican Republic blood donors; it is focused on Santo Domingo, the capital of the country, which has the largest blood donation activity. We also aim at comparing our findings with published data from neighboring countries. PATIENTS AND METHODS: We performed a retrospective cross-sectional study of 10 blood centers of Santo Domingo, which reported HTLV and the other blood-transmitted infections in full. They represent more than 40% of the province’s blood donations. Annual seroprevalence of HTLV-1/2, period prevalence (2012-2017), and time trend were determined. RESULTS: A total of 352,960 blood donations were evaluated. The HTLV-1/2 period prevalence was 0.26% (929/352,960) (95% CI: 0.24–0.28%). We also found a marked predominance of replacement donation (90.4%) in comparison to voluntary contributions (9.6%). Therefore, this blood donor study may provide clues on the general prevalence of the infection. CONCLUSIONS: Seroprevalence of HTLV-1/2 in blood donors of Santo Domingo, Dominican Republic, showed a relatively low and steady trend in the studied period. Sociedad Española de Quimioterapia 2020-12-11 2021 /pmc/articles/PMC7876899/ /pubmed/33305921 http://dx.doi.org/10.37201/req/117.2020 Text en © The Author 2020 https://creativecommons.org/licenses/by-nc/4.0/ Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Original
Eusebio-Ponce, Emiliana
Candel, Francisco Javier
Paulino-Ramirez, Robert
Serrano-García, Irene
Anguita, Eduardo
Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title_full Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title_fullStr Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title_full_unstemmed Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title_short Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017
title_sort seroprevalence and trends of htlv-1/2 among blood donors of santo domingo, dominican republic, 2012-2017
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876899/
https://www.ncbi.nlm.nih.gov/pubmed/33305921
http://dx.doi.org/10.37201/req/117.2020
work_keys_str_mv AT eusebioponceemiliana seroprevalenceandtrendsofhtlv12amongblooddonorsofsantodomingodominicanrepublic20122017
AT candelfranciscojavier seroprevalenceandtrendsofhtlv12amongblooddonorsofsantodomingodominicanrepublic20122017
AT paulinoramirezrobert seroprevalenceandtrendsofhtlv12amongblooddonorsofsantodomingodominicanrepublic20122017
AT serranogarciairene seroprevalenceandtrendsofhtlv12amongblooddonorsofsantodomingodominicanrepublic20122017
AT anguitaeduardo seroprevalenceandtrendsofhtlv12amongblooddonorsofsantodomingodominicanrepublic20122017